PubRank

Suying Li

Author PubWeight™ 93.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012 5.70
2 Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011 5.47
3 Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010 3.11
4 US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011 2.90
5 Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2005 2.81
6 Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med 2012 2.74
7 US Renal Data System 2013 Annual Data Report. Am J Kidney Dis 2014 2.68
8 US Renal Data System 2012 Annual Data Report. Am J Kidney Dis 2013 2.54
9 Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med 2012 2.24
10 Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010 2.18
11 Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis 2007 2.16
12 Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 2007 2.14
13 United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis 2009 2.14
14 Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 2008 2.11
15 Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008 2.01
16 Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2011 1.88
17 CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008 1.71
18 Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003 1.70
19 Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009 1.52
20 Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 2008 1.46
21 No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney Int 2013 1.38
22 CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008 1.37
23 Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2013 1.29
24 The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2004 1.18
25 Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2008 1.18
26 Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 2009 1.16
27 Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008 1.16
28 Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP). Clin J Am Soc Nephrol 2011 1.13
29 Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008 1.12
30 Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010 1.09
31 Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc 2012 1.07
32 Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2013 1.06
33 Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis 2011 1.04
34 Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2009 1.04
35 Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis 2009 1.03
36 Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008 1.03
37 Association of provider-patient visit frequency and patient outcomes on hemodialysis. J Am Soc Nephrol 2012 1.02
38 Association of educational attainment with chronic disease and mortality: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2011 1.01
39 Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2012 1.01
40 Associations between access to care and awareness of CKD. Am J Kidney Dis 2012 1.00
41 Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease. Metabolism 2009 1.00
42 Access to health care among adults evaluated for CKD: findings from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2012 0.99
43 Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep 2011 0.98
44 Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol 2009 0.97
45 Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J Clin Hypertens (Greenwich) 2010 0.94
46 Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program. Cardiorenal Med 2011 0.93
47 In-depth proteomic analysis of the human sperm reveals complex protein compositions. J Proteomics 2012 0.93
48 Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants. Am J Kidney Dis 2012 0.92
49 The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2013 0.90
50 Provider and care characteristics associated with timing of dialysis initiation. Clin J Am Soc Nephrol 2014 0.90
51 Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin Nephrol 2010 0.89
52 Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program. Am J Nephrol 2008 0.88
53 Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2011 0.88
54 Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010 0.88
55 Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2012 0.86
56 The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease. Cardiorenal Med 2011 0.85
57 Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2009 0.85
58 The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program. J Clin Endocrinol Metab 2012 0.84
59 The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program. Cardiorenal Med 2013 0.82
60 Complete oxidation of formaldehyde at ambient temperature over supported Pt/Fe2O3 catalysts prepared by colloid-deposition method. J Hazard Mater 2010 0.80
61 Variation in Cost and Quality in Kidney Transplantation. Transplantation 2015 0.80
62 Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP). BMC Nephrol 2012 0.78
63 Variation in structure and delivery of care between kidney transplant centers in the United States. Transplantation 2014 0.75
64 Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP). Diabetes Care 2010 0.75
65 Predictors of provider-patient visit frequency during hemodialysis. Am J Nephrol 2013 0.75
66 Hemodialysis patient outcomes: provider characteristics. Am J Nephrol 2014 0.75
67 A New Method for Cone-Beam Computed Tomography Geometric Parameters Estimation. J Comput Assist Tomogr 2016 0.75
68 Participant follow-up in the Kidney Early Evaluation Program (KEEP) after initial detection. Am J Kidney Dis 2008 0.75
69 Evaluation of the separation performance of polyvinylpyrrolidone as a virtual stationary phase for chromatographic NMR. Magn Reson Chem 2014 0.75